U.S. stock night trading volatility: Molina Healthcare fell 7.10% in after-hours trading, raising concerns over Medicaid cost pressures
I'm LongbridgeAI, I can summarize articles.Molina Healthcare fell 7.10% in after-hours trading; UnitedHealth rose 0.02% with a trading volume of USD 114,500; Elevance Health fell 0.02% with a trading volume of USD 778
U.S. Stock Night Market Movements
Molina Healthcare fell 7.10% in the night market. Based on recent key news:
-
On July 23, Molina Healthcare's stock price dropped mainly due to market concerns over Medicaid cost pressures. The company reported a 4.9% year-over-year decline in quarterly revenue, but it still exceeded analyst expectations, with adjusted earnings per share surpassing forecasts and a medical cost ratio of 92.2%. These factors led investors to question its future profitability, impacting the stock price.
-
On July 23, Molina Healthcare's second-quarter financial report showed that despite a significant year-over-year decline in revenue and earnings, operating cash flow improved. The company raised its full-year adjusted earnings per share guidance to at least $5.25, with Medicaid and Medicare business performance meeting or exceeding expectations. This financial data prompted the market to reassess its long-term growth potential.
-
On July 22, analysts maintained a hold rating on Molina Healthcare, believing that five other stocks offer better investment value. The analysts' cautious stance reflects market concerns about the company's competitiveness in the current economic environment. The healthcare industry faces cost pressures and needs to pay attention to policy changes.
Stocks with High Trading Volume in the Industry
UnitedHealth rose 0.02% in the night market. Based on recent key news:
-
On July 20, UnitedHealth reported second-quarter results that exceeded expectations, with adjusted earnings per share of $6.38, surpassing analyst expectations of $4.86, and revenue reaching $112.03 billion, driving the stock price up by 0.6%. Source: Gelonghui
-
On July 21, Morgan Stanley raised its target price for UnitedHealth from $468 to $529, maintaining an "Overweight" rating, reflecting market confidence in the company's future growth. Source: Gelonghui
-
On July 21, a FactSet survey showed that analysts raised the median target price for UnitedHealth to $490, with the stock performing better than the market. Source: FactSet The healthcare industry has recently shown strong performance, with significant capital inflows.
Elevance Health fell 0.02% in the night market. Based on recent news:
-
On July 20, Sequoia Strategy Composite disclosed in its second-quarter report that it had reduced its investment in Elevance Health. This news weakened market confidence in the stock, leading to a decline in its price.
-
On July 19, Elevance Health's financial report showed that its earnings did not meet market expectations. Despite revenue growth, declining profit margins raised investor concerns, putting pressure on the stock price.
-
On July 18, the market expressed concerns about the overall outlook for the healthcare industry. Due to policy uncertainty and rising costs, investor confidence in the sector weakened, affecting the performance of multiple stocks, including Elevance Health The healthcare industry faces policy uncertainty and rising cost risks
